News › Industry News, News

Allergan Completes Vitae Tender Offer

November 1, 2016

Allergan completed their tender offer to purchase all outstanding shares of Vitae Pharmaceuticals, Inc., a clinical-stage biotechnology company.
A tender offer occurs when an acquiring company offers to buy another company’s stock from shareholders at a specified price. The next step is a merger. Allergan offered to purchase all outstanding shares of Vitae for $21.00 per share, in cash, for a total transaction value of approximately $639 million.
Read More >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • FDA Sends Peptide ‘Interim Access Policy’ to White House for Review
    • New ACOG Menopause Guidelines Expand Hormone Therapy and Symptom Treatment Recommendations
    • Galderma to Acquire ZO Skin Health for $1.5 Billion
    • AscendPoint Agency Acquires Medical Marketing Whiz
    • PracticeQ Becomes Platinum Vendor Affiliate with the American Med Spa Association
Advertisement